25.7 C
New York
Thursday, June 4, 2026

Tag: silica

newssourceFORcompanyinformationcontent1marketreleases

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Microgrid Market to Grow at a CAGR of 15.6% from 2025 to 2032 | SkyQuest Technology Consulting

The global microgrid market is witnessing rapid growth, primarily driven by the rising demand for energy resilience and reliability, especially in the face of grid...

Microgrid Market to Grow at a CAGR of 15.6% from 2025 to 2032 | SkyQuest Technology Consulting

The global microgrid market is witnessing rapid growth, primarily driven by the rising demand for energy resilience and reliability, especially in the face of grid...

Aurion Intersects 4.42 g/t Au over 32.55 m at Kaaresselkä, Risti Property

Drill intercepts include 4.42 g/t Au over 32.55 m, 4.29 g/t Au over 4.45 m and 4.69 g/t Au over 3.00 mHigh grade mineralization...

Ecovyst Reports Second Quarter 2025 Results

WAYNE, Pa., Aug. 7, 2025 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading integrated and innovative global provider of advanced...

LaPrairie Works Takes Over Provincial Highway Maintenance Operations in CMA 519 near Hanna and Oyen, Alberta

CALGARY, AB, Aug. 5, 2025 /CNW/ - LaPrairie Works, leader in highway and bridge maintenance and civil infrastructure construction in Western Canada, is pleased...

Fireweed Intersects Sulphide Mineralization at Boundary Zone Muon Targets

TSXV: FWZOTCQX: FWEDFFSE: M0G VANCOUVER, BC, July 30, 2025 /CNW/ - Fireweed Metals Corp. ("Fireweed" or the "Company") (TSXV: FWZ) (OTCQX: FWEDF) is pleased to report the...

COPPER GIANT EXTENDS MOCOA’S NEAR SURFACE HIGH-GRADE WITH 567-METRES AT 0.54% COPPER & 0.07% MOLYBDENUM

Hole MD-047 returned 1,004-metres of continuous copper and molybdenum mineralization from surface with the entire hole averaging 0.57% CuEq* (0.39% Cu and 0.04% Mo)—highlighting one...

Scout Drilling Results Extend Polymetallic Mineralization Footprints at Chita; Exploration Identifies Compelling Regional Targets

TSX-V: MSR TORONTO, July 29, 2025 /CNW/ - Minsud Resources Corp. (TSXV: MSR) ("Minsud" or the "Company"), is pleased to announce the significant results received from its...

Precipitated Silica Market Company Evaluation Report 2025 | Evonik, Solvay, and Tata Lead in Silica Via Innovation, Sustainability, and Strategic Global Expansion

The Precipitated Silica Market Companies Quadrant presents an in-depth analysis of the global precipitated silica market, highlighting top industry players like Evonik Industries AG, Solvay SA, and Tata Chemicals Ltd. With over 40 companies evaluated, the Top 15 emerge as quadrant leaders, driven by innovations, strategic expansions, and a focus on sustainability. The increasing demand across automotive, agriculture, cosmetics, and electronics sectors underscores precipitated silica's versatility. This customizable silicon dioxide improves tire efficiency, supports crop protection, and enhances cosmetic formulations. As industries prioritize sustainability, the role of precipitated silica continues to grow. 
The Precipitated Silica Market Companies Quadrant presents an in-depth analysis of the global precipitated silica market, highlighting top industry players like Evonik Industries AG, Solvay SA, and Tata Chemicals Ltd. With over 40 companies evaluated, the Top 15 emerge as quadrant leaders, driven by innovations, strategic expansions, and a focus on sustainability. The increasing demand across automotive, agriculture, cosmetics, and electronics sectors underscores precipitated silica's versatility. This customizable silicon dioxide improves tire efficiency, supports crop protection, and enhances cosmetic formulations. As industries prioritize sustainability, the role of precipitated silica continues to grow.

FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.1

Ecovyst to Host Second Quarter 2025 Earnings Conference Call and Webcast on Thursday, August 7, 2025 at 11:00 a.m. ET

WAYNE, Pa., July 24, 2025 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT), a leading integrated and innovative global provider of advanced materials, specialty catalysts and services,...

Relativity Networks Secures $6M Seed Funding to Power the Next-Generation Fiber-Optic Cable for Data Centers, Raising Total to $10.6M

Investors' backing bolsters Relativity Networks' ability to meet the insatiable demand for a data transmission technology that hyperscalers require for the AI-powered economy. ORLANDO, Fla.,...

June 2025 Quarterly Exploration Results

82km of drilling and $9M invested in resource development and exploration in Q4, FY25 PERTH, Western Australia, July 23, 2025 /CNW/ - Westgold Resources Limited...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSilica

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers